Editas Medicine Inc (NAS:EDIT)
$ 5.3 -0.13 (-2.39%) Market Cap: 435.86 Mil Enterprise Value: 184.52 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 52/100

Editas Medicine Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 12:00AM GMT
Release Date Price: $9.99 (-2.77%)
Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Final session of the first day of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And this afternoon, we have Editas Medicine with us represented by Gilmore O'Neill, Chief Executive Officer. Thanks for joining us.

Gilmore Oâ;Neill
Editas Medicine, Inc. - President, CEO & Director

Thanks very much, Greg.

Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Maybe we could start off with some opening remarks and then jump into Q&A.

Gilmore Oâ;Neill
Editas Medicine, Inc. - President, CEO & Director

Sure. Thanks very much for the opportunity, Greg, and thanks to BofA for hosting a wonderful meeting. We've had some really great interactions today. Editas is a very exciting place at this moment. I joined just 10 months ago. And in that time, I hired a new CMO, focusing on driving execution.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot